Cinctive Capital Management LP Tyra Biosciences, Inc. Transaction History
Cinctive Capital Management LP
- $1.72 Billion
- Q3 2024
A detailed history of Cinctive Capital Management LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 22,900 shares of TYRA stock, worth $348,080. This represents 0.03% of its overall portfolio holdings.
Number of Shares
22,900Holding current value
$348,080% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$158 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$98 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$70.9 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$67 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$61.6 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $638M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...